Xue-chu Zhen
Jiangsu Key Laboratory Of Drug Discovery And Translational Research For Brain Diseases
Suzhou, 215123, China
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Rational Design of Gi-biased CB1 Agonists for the Next Generation of Analgesic Drug.
Journal: Neuroscience bulletin
Published: May 07, 2026
Neuromodulatory roles of the sigma-1 receptor in behavior and drug sensitization during development.
Neuromodulatory roles of the sigma-1 receptor in behavior and drug sensitization during development.
Journal: Acta pharmacologica Sinica
Published: December 29, 2025
Discovery of New N-H Aporphine Derivatives As Brain-Penetrant Gq-Biased 5-HT2C Receptor Agonists and Dual 5-HT2C/5-HT2A Receptor Agonists.
Journal: Journal of medicinal chemistry
Published: October 18, 2025
Sonic Hedgehog-Gli1 signaling promotes microglial activation via the IKKβ/NF-κB pathway.
Journal: Acta pharmacologica Sinica
Published: September 24, 2025
Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma.
Journal: Biochemical and biophysical research communications
Published: August 20, 2025
Selective recognition memory impairment in mitochondrial hydroxylase Clk1 mutant mice, rescued by antipsychotics.
Journal: Acta pharmacologica Sinica
Published: March 07, 2025
Sigma-1 receptor positive allosteric modulator promotes neuronal survival and improves cognitive deficits in AD mice via sigma-1 receptor/ERK pathway.
Journal: Acta pharmacologica Sinica
Published: February 10, 2025
Polo-like kinase 2 promotes microglial activation via regulation of the HSP90α/IKKβ pathway.
Journal: Cell reports
Published: April 03, 2024
Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 22, 2023
The classical D1 dopamine receptor antagonist SCH23390 is a functional sigma-1 receptor allosteric modulator.
Journal: Acta pharmacologica Sinica
Published: October 19, 2023
Targeted to neuronal organelles for CNS drug development.
Journal: Advanced drug delivery reviews
Published: April 30, 2023
Last Updated: 09/26/2026